| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A phase 2 trial of the histone deacetylase inhibitor panobinostat for graft-versus-host disease prevention
|
Perez, Lia
|
|
|
5 |
13 |
p. 2740-2750
|
artikel
|
| 2 |
A thrombin-PAR1/2 feedback loop amplifies thromboinflammatory endothelial responses to the viral RNA analogue poly(I:C)
|
Subramaniam, Saravanan
|
|
|
5 |
13 |
p. 2760-2774
|
artikel
|
| 3 |
Autoimmune- and complement-mediated hematologic condition recrudescence following SARS-CoV-2 vaccination
|
Portuguese, Andrew Jay
|
|
|
5 |
13 |
p. 2794-2798
|
artikel
|
| 4 |
Comorbidities are risk factors for hospitalization and serious COVID-19 illness in children and adults with sickle cell disease
|
Mucalo, Lana
|
|
|
5 |
13 |
p. 2717-2724
|
artikel
|
| 5 |
Editorial Board
|
|
|
|
5 |
13 |
p. i
|
artikel
|
| 6 |
Essential role for Gata2 in modulating lineage output from hematopoietic stem cells in zebrafish
|
Gioacchino, Emanuele
|
|
|
5 |
13 |
p. 2687-2700
|
artikel
|
| 7 |
Final results of the PUPs B-LONG study: evaluating safety and efficacy of rFIXFc in previously untreated patients with hemophilia B
|
Nolan, Beatrice
|
|
|
5 |
13 |
p. 2732-2739
|
artikel
|
| 8 |
Gowin K, Ballen K, Ahn KW, et al. Survival following allogeneic transplant in patients with myelofibrosis. Blood Adv. 2020;4(9):1965-1973.
|
|
|
|
5 |
13 |
p. 2751
|
artikel
|
| 9 |
Phase 3 randomized trial of chemotherapy with or without oblimersen in older AML patients: CALGB 10201 (Alliance)
|
Walker, Alison R.
|
|
|
5 |
13 |
p. 2775-2787
|
artikel
|
| 10 |
Polatuzumab vedotin as a salvage and bridging treatment in relapsed or refractory large B-cell lymphomas
|
Liebers, Nora
|
|
|
5 |
13 |
p. 2707-2716
|
artikel
|
| 11 |
Prognostic impact of posttransplant FDG PET/CT scan in multiple myeloma
|
Kaddoura, Marcella
|
|
|
5 |
13 |
p. 2753-2759
|
artikel
|
| 12 |
Qi S, Milgrom S, Dabaja B, et al. Two distinct prognostic groups in advanced-stage Hodgkin lymphoma revealed by the presence and site of bulky disease. Blood Adv. 2020;4(9):2064-2072.
|
|
|
|
5 |
13 |
p. 2793
|
artikel
|
| 13 |
RPS15 mutations rewire RNA translation in chronic lymphocytic leukemia
|
Ntoufa, Stavroula
|
|
|
5 |
13 |
p. 2788-2792
|
artikel
|
| 14 |
Search for AL amyloidosis risk factors using Mendelian randomization
|
Saunders, Charlie N.
|
|
|
5 |
13 |
p. 2725-2731
|
artikel
|
| 15 |
Single-cell ATAC-seq reveals GATA2-dependent priming defect in myeloid and a maturation bottleneck in lymphoid lineages
|
Avagyan, Serine
|
|
|
5 |
13 |
p. 2673-2686
|
artikel
|
| 16 |
Wild-type HIV infection after treatment with lentiviral gene therapy for β-thalassemia
|
Hongeng, Suradej
|
|
|
5 |
13 |
p. 2701-2706
|
artikel
|
| 17 |
Zhou Z, Nath R, Cerny J, et al. Reduced intensity conditioning for acute myeloid leukemia using melphalan- vs busulfan-based regimens: a CIBMTR report. Blood Adv. 2020;4(13):3180-3190.
|
|
|
|
5 |
13 |
p. 2752
|
artikel
|
Tijdschrift beschrijving